Scholarly Index
Masamitsu Shimazawa
Gifu Pharmaceutical University; 13,705 total citations; 484 total publications; best world rank #230
Gifu Pharmaceutical University
13,705Total citations
484Total publications
63H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Retinal Diseases and Treatments | Lifetime | 502 | JP 35 | 98.39 |
| Endoplasmic Reticulum Stress and Disease | Lifetime | 403 | JP 42 | 97.33 |
| Bee Products Chemical Analysis | Lifetime | 319 | JP 7 | 96.57 |
| Retinal Development and Disorders | Lifetime | 478 | JP 24 | 97.55 |
| Neuroprotection in Stroke and Neurodegeneration | Lifetime | 562 | JP 41 | 94.92 |
| RNA regulation and disease | Lifetime | 673 | JP 53 | 95.08 |
| Amyotrophic Lateral Sclerosis Research | Lifetime | 702 | JP 62 | 93.35 |
| Connexins and lens biology | Lifetime | 855 | JP 63 | 92.13 |
| Saffron Plant Research Studies | Lifetime | 230 | JP 17 | 85.64 |
| Calpain Protease Function and Regulation | Lifetime | 850 | JP 142 | 74.55 |
| Phytochemical and Pharmacological Studies | Lifetime | 738 | JP 20 | 71.70 |
| Retinal Development and Disorders | 2021-2025 | 333 | JP 17 | 89.63 |
| Connexins and lens biology | 2021-2025 | 277 | JP 19 | 70.93 |
| Plant-derived Lignans Synthesis and Bioactivity | 2021-2025 | 373 | JP 7 | 36.65 |